CVac    SH_AO1_R_T F_AO1_R  ‘ Cancer Vaccine ’   IH1_Z AH0 P_AH0_T_EH1_N_SH_AH0_L immunotherapeutic EY1_JH_AH0_N_T DH_AE1_T    D_IH0_V_EH1_L_AH0_P_T IH0_N Australia CVac W_AA1_Z D_IH0_V_EH1_L_AH0_P_T B_AY1 DH_AH0 B_AY2_OW0_T_EH2_K_N_AA1_L_AH0_JH_IY0 K_AH1_M_P_AH0_N_IY2 Prima BioMed    Nasdaq    PBMD    TH_R_UW1 T_UW1 Phase II K_L_IH1_N_AH0_K_AH0_L S_T_AH1_D_IY0_Z B_IH0_T_W_IY1_N 2001 AH0_N_D 2015 After IH2_N_K_AH0_N_K_L_UW1_S_IH0_V K_L_IH1_N_AH0_K_AH0_L D_EY1_T_AH0 IH0_N OW0_V_EH1_R_IY2_AH0_N K_AE1_N_S_ER0 2013 AH0_N_D 2014    Prima AH0_N_AW1_N_S_T IH0_N February 2015 DH_AE1_T IH1_T HH_AE1_D S_IY1_S_T R_AH0_K_R_UW1_T_IH0_NG IH1_N_T_UW0 CVAc K_L_IH1_N_AH0_K_AH0_L S_T_AH1_D_IY0_Z AH0_N_D W_AA1_Z S_IY1_K_IH0_NG K_AH0_M_ER1_SH_AH0_L P_AA1_R_T_N_ER0_Z F_AO1_R DH_AH0 P_R_AA1_D_AH0_K_T    CVac IH1_Z AE1_N EH1_K_S V_IY1_V_OW0 D_EH0_N_D_R_IH1_T_IH0_K S_EH1_L P_R_AY1_M_IH0_NG T_EH0_K_N_AA1_L_AH0_JH_IY0 IH2_N_V_AA1_L_V_IH0_NG MFP    AO1_R mannan F_Y_UW1_ZH_AH0_N P_R_OW1_T_IY2_N    W_EH1_R AH0 F_Y_UW1_ZH_AH0_N P_R_OW1_T_IY2_N AH1_V MUC1 AH0_N_D Glutathione transferase IH1_Z K_AH1_P_AH0_L_D T_UW1 AA1_K_S_AH0_D_AY2_Z_D polymannose The D_EH0_N_D_R_IH1_T_IH0_K S_EH1_L_Z AA1_R DH_AH0 orchestrators AH1_V DH_AH0 IH2_M_Y_UW1_N S_IH1_S_T_AH0_M  ‘ Priming ’  D_EH0_N_D_R_IH1_T_IH0_K S_EH1_L_Z IH2_N_V_AA1_L_V_Z IH0_K_S_P_OW1_Z_IH0_NG DH_OW1_Z S_EH1_L_Z T_UW1 D_IH0_Z_IY1_Z AE1_N_T_IH0_JH_AH0_N_Z IH0_N AO1_R_D_ER0 T_UW1 G_EH1_T DH_AH0 IH2_M_Y_UW1_N S_IH1_S_T_AH0_M T_UW1 P_R_AA1_P_ER0_L_IY0 R_EH1_K_AH0_G_N_AY2_Z DH_AH0 AE1_N_T_AH0_JH_AH0_N AH0_N_D M_AW1_N_T AE1_N AH0_P_R_OW1_P_R_IY0_AH0_T R_IH0_S_P_AA1_N_S    With CVac DH_IH1_S T_EY1_K_S P_L_EY1_S AW1_T_S_AY1_D DH_AH0 B_AA1_D_IY0 AH1_V DH_AH0 P_EY1_SH_AH0_N_T    EH1_K_S V_IY1_V_OW0     W_IH1_DH D_EH0_N_D_R_IH1_T_IH0_K S_EH1_L_Z AH0_B_T_EY1_N_D B_AY1 leukapheresis The AE1_N_T_AH0_JH_AH0_N IH0_N DH_IH1_S K_EY1_S IH1_Z MUC1      N_OW1_N T_UW1 B_IY1 overexpressed AA1_N AH0 V_ER0_AY1_AH0_T_IY0 AH1_V K_AE1_N_S_ER0 S_EH1_L_Z    AH0_N_D IH0_N CVac MUC1 IH1_Z K_AA2_N_JH_AH0_G_EY1_T_IH0_D T_UW1 DH_AH0 K_AA2_R_B_OW0_HH_AY1_D_R_EY2_T mannan T_UW1 F_AH0_S_IH1_L_AH0_T_EY2_T AH1_P_T_EY2_K B_AY1 DH_AH0 D_EH0_N_D_R_IH1_T_IH0_K S_EH1_L_Z CVAc K_AE1_N B_IY1 AH0_D_M_IH1_N_IH0_S_T_ER0_D subcutaneously    W_EH0_R_AE1_Z Provenge IH1_Z IH2_N_T_R_AH0_V_IY1_N_AH0_S    CVac ER0_IH1_JH_AH0_N_EY2_T_AH0_D IH0_N DH_AH0 M_IH1_D 1990s AE1_T DH_AH0 Austin Research Institute    AH0 M_EH1_D_AH0_K_AH0_L R_IY0_S_ER1_CH F_AH0_S_IH1_L_IH0_T_IY0 DH_EH1_N AH0_S_OW1_S_IY0_EY2_T_AH0_D W_IH1_DH Melbourne EH1_S Austin Hospital    AH0_N_D DH_AE1_T M_ER1_JH_D W_IH1_DH DH_AH0 Burnet Institute IH0_N 2006 The ER0_IH1_JH_AH0_N_AH0_L V_ER1_ZH_AH0_N AH1_V DH_AH0 P_R_AA1_D_AH0_K_T W_AA1_Z D_IH0_V_EH1_L_AH0_P_T IH0_N DH_AH0 L_AE1_B_R_AH0_T_AO2_R_IY0 AH1_V DH_AH0 Austin    Professor Ian McKenzie IH0_N 1993    CVac TH_EH1_R_AH0_P_IY0 W_AA1_Z ER0_IH1_JH_AH0_N_AH0_L_IY0 IH2_N_T_EH1_N_D_IH0_D T_UW1 B_IY1 IH0_N V_IY1_V_OW0 B_AH1_T DH_AH0 Austin R_IY1_S_ER0_CH_ER0_Z S_T_AA1_R_T_AH0_D G_EH1_T_IH0_NG B_EH1_T_ER0 R_IH0_Z_AH1_L_T_S IH0_N EH1_K_S V_IY1_V_OW0 TH_EH1_R_AH0_P_IY0 Prima BioMed W_AA1_Z F_AO1_R_M_D ER0_AW1_N_D 2001 T_UW1 commercialise AH0 N_AH1_M_B_ER0 AH1_V Austin Research Institute P_R_AA1_JH_EH0_K_T_S IH2_N_K_L_UW1_D_IH0_NG CVac The K_AH1_M_P_AH0_N_IY2 W_AA1_Z T_EY1_K_AH0_N P_AH1_B_L_IH0_K IH0_N July 2001 AA1_N DH_AH0 ASX IH0_N AH0 R_IH0_V_ER1_S T_EY1_K_OW2_V_ER0 AH1_V AH0 D_IH0_F_AH1_NG_K_T M_IH1_N_ER0_AH0_L IH0_K_S_P_L_AO1_R_ER0 K_AO1_L_D Prima Resources    CVac AH1_L_T_AH0_M_AH0_T_L_IY0 EH1_N_D_AH0_D AH1_P AE1_Z Prima BioMed EH1_S K_AO1_R P_R_AA1_JH_EH0_K_T AH0_N_T_IH1_L Prima EH1_S AE2_K_W_AH0_Z_IH1_SH_AH0_N AH1_V DH_AH0 French B_AY2_OW0_T_EH2_K_N_AA1_L_AH0_JH_IY0 K_AH1_M_P_AH0_N_IY2 Immutep SA IH0_N 2014 CVac W_AA1_Z AH0_P_R_UW1_V_D F_AO1_R Y_UW1_S B_AY1 DH_AH0 Dubai Health City Authority IH0_N May 2011    CVac W_AA1_Z M_AE2_N_Y_AH0_F_AE1_K_CH_ER0_D IH0_N Germany B_AY1 Fraunhofer IZI    Das Fraunhofer Institut EH1_F AA1_R Zelltherapie AH1_N_D Immunologie     AE1_N IH1_N_S_T_IH0_T_UW2_T AH1_V DH_AH0 Fraunhofer Society IH0_N Leipzig    Saxony    The Fraunhofer IZI W_AA1_Z AO1_TH_ER0_AY2_Z_D T_UW1 M_AE2_N_Y_AH0_F_AE1_K_CH_ER0 DH_AH0 T_R_IY1_T_M_AH0_N_T IH0_N Europe IH0_N L_EY1_T 2011 AE1_F_T_ER0 M_IY1_T_IH0_NG K_R_AY0_T_IH1_R_IY0_AH0 L_EY1_D D_AW1_N B_AY1 DH_AH0 German Arzneimittelgesetz    Drug Law Prima IH2_N_T_EH1_N_D_IH0_D DH_AE1_T IH1_T_S P_R_AA1_D_AH0_K_T W_UH1_D B_IY1 M_AE2_N_Y_AH0_F_AE1_K_CH_ER0_D AE1_T DH_IH1_S W_AH1_N S_EH1_N_T_R_AH0_L L_OW0_K_EY1_SH_AH0_N    W_IH1_DH P_EY1_SH_AH0_N_T B_L_AH1_D B_IY1_IH0_NG F_L_OW1_N T_UW1 Leipzig AH0_N_D P_R_AY1_M_D D_EH0_N_D_R_IH1_T_IH0_K S_EH1_L_Z B_IY1_IH0_NG SH_IH1_P_T B_AE1_K T_UW1 DH_AH0 R_EH1_L_AH0_V_AH0_N_T T_R_AY1_AH0_L S_AY1_T